← Leaderboards
Paul Hauser
Dormatarg, Inc.
$556,070
Attributed
$556,070
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $296.9K · FY2009–12$500K$375K$250K$125K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$556,070 · 2
By mechanism
R43$556,070 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Recurrence”
- Philip J Disaia · University Of California Irvine$95,481,777
- David Heimbrook · Leidos Biomedical Research, Inc.$87,033,539
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
- Myron S Cohen · Family Health International$84,793,830
- Lawrence Corey · Fred Hutchinson Cancer Center$59,594,035
- Dan H. Barouch · Fred Hutchinson Cancer Center$59,594,035
Research focus
RecurrencePharmaceutical PreparationsLeadPreventXenograft ModelChemotherapyExtracellular MatrixLaboratoriesOperative Surgical ProceduresPlasticsResistanceScreening ProcedureCancer CellBaseBinding (Molecular Function)Drug Delivery SystemsIn Vivo ModelKillingsMalignant NeoplasmsNeoplasm MetastasisCellsCancer PatientBusinessesBreast Cancer Model